1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Msi2 maintains the MLL leukemia stem cell regulatory program
    Meeting Abstract

    Park, S. M.; Gonen, M.; Vu, L. P.; Minuesa, G.; Tivnan, P.; Barlowe, T.; Taggart, J.; Lu, Y. H.; Deering, R. P.; Hacohen, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Type II inhibition of JAK2 with NVP-CHZ868 reverses type I JAK inhibitor persistence and demonstrates increased efficacy in MPN models
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Koppikar, P.; Guryanova, O. A.; Kleppe, M.; McKenney, A. S.; Sellers, W. R.; Hofmann, F.; Baffert, F.; Gaul, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • MLL exons 4-8 duplication in a patient with CALR-mutated essential thrombocythemia
    Meeting Abstract

    Mantha, S.; Levine, R. L.; Rampal, R. K.
    Blood (2014)

    Fulltext@MSK | Save
  • Loss of TET2 function in myelodysplastic syndrome results in intragenic hypermethylation and alterations in mRNA splicing
    Meeting Abstract

    Lord, A. M.; Clement, K.; Schneider, R. K.; Marie, M.; Chen, M. C.; Levine, R. L.; Mullally, A.; Galili, N.; Ali, A. M.; Raza, A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A comparison of human CMVpp65-specific central memory and effector memory CD8 T-cells when stimulated in-vivo with IL-2 or IL-15/IL-15R alpha complex in a murine xenograft model of adoptive cell therapy
    Meeting Abstract

    Kuo, T. Y.; Hasan, A.; O'Reilly, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • Issues in categorization and management of pediatric patients with myeloproliferative neoplasms
    Meeting Abstract

    Kucine, N.; Levine, R. L.; Bussel, J. B.
    Blood (2014)

    Fulltext@MSK | Save
  • Patient derived xenograft (PDX) models recapitulate the genomic-driver composition of acute leukemia samples
    Meeting Abstract

    Krivtsov, A. V.; Wang, X. J.; Farnoud, N. R.; Hadler, M.; Martin, M. S.; Knapp, K. M.; Stein, E. M.; Lipson, D.; Nahas, M. K.; Stephens, P. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Phase I trial of targeted alpha-particle therapy using actinium-225 (Ac-225)-lintuzumab (anti-CD33) in combination with low-dose cytarabine (LDAC) for older patients with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Douer, D.; Estey, E. H.; Kantarjian, H. M.; Wahl, R. L.; Earle, D.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic profiling combining DNA and RNA analysis of 112 formalin-fixed paraffin-embedded diffuse large B cell lymphoma specimens identifies a high frequency of clinically relevant genomic alterations
    Meeting Abstract

    Intlekofer, A. M.; Hilden, P.; Seshan, V. E.; Copeland, A. R.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Leukemia-associated oncometabolite 2-hydroxyglutarate regulates epigenetic modifications in response to oxygen availability in cells without IDH1/2 mutations
    Meeting Abstract

    Intlekofer, A. M.; DeMatteo, R. G.; Finley, L. W.; Cross, J. R.; Thompson, C. B.
    Blood (2014)

    Fulltext@MSK | Save